Utah Medical Products, Inc. (UTMD)
74.23
-0.83
(-1.11%)
USD |
NASDAQ |
Oct 23, 16:00
74.24
+0.01
(+0.01%)
After-Hours: 20:00
Utah Medical Products Enterprise Value : 150.66M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 150.66M |
| October 22, 2026 | 153.29M |
| October 21, 2026 | 152.21M |
| October 20, 2026 | 153.33M |
| October 19, 2026 | 151.67M |
| October 16, 2026 | 151.55M |
| October 15, 2026 | 152.85M |
| October 14, 2026 | 152.44M |
| October 13, 2026 | 152.18M |
| October 12, 2026 | 151.23M |
| October 09, 2026 | 151.64M |
| October 08, 2026 | 149.53M |
| October 07, 2026 | 148.18M |
| October 06, 2026 | 149.39M |
| October 05, 2026 | 147.74M |
| October 02, 2026 | 150.34M |
| October 01, 2026 | 151.04M |
| September 30, 2026 | 150.09M |
| September 29, 2026 | 151.23M |
| September 28, 2026 | 149.77M |
| September 25, 2026 | 148.78M |
| September 24, 2026 | 150.60M |
| September 23, 2026 | 151.42M |
| September 22, 2026 | 156.68M |
| September 21, 2026 | 149.74M |
| Date | Value |
|---|---|
| September 18, 2026 | 148.08M |
| September 17, 2026 | 148.81M |
| September 16, 2026 | 148.40M |
| September 15, 2026 | 150.21M |
| September 14, 2026 | 137.61M |
| September 11, 2026 | 134.55M |
| September 10, 2026 | 134.33M |
| September 09, 2026 | 134.59M |
| September 08, 2026 | 132.80M |
| September 04, 2026 | 138.98M |
| September 03, 2026 | 137.74M |
| September 02, 2026 | 140.70M |
| September 01, 2026 | 141.08M |
| August 31, 2026 | 139.07M |
| August 28, 2026 | 144.29M |
| August 27, 2026 | 141.21M |
| August 26, 2026 | 138.31M |
| August 25, 2026 | 138.53M |
| August 24, 2026 | 140.63M |
| August 21, 2026 | 140.41M |
| August 20, 2026 | 140.00M |
| August 19, 2026 | 142.22M |
| August 18, 2026 | 141.84M |
| August 17, 2026 | 136.15M |
| August 14, 2026 | 138.66M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.10B |
| AngioDynamics, Inc. | 501.34M |
| Alphatec Holdings, Inc. | 2.205B |
| AtriCure, Inc. | 2.906B |
| Baxter International, Inc. | 19.76B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.787M |
| Revenue (Quarterly) | 8.621M |
| Total Expenses (Quarterly) | 5.834M |
| EPS Diluted (Quarterly) | 0.8763 |
| Gross Profit Margin (Quarterly) | 55.71% |
| Profit Margin (Quarterly) | 32.33% |
| Earnings Yield | 4.50% |
| Operating Earnings Yield | 4.50% |
| Normalized Earnings Yield | 4.557 |